INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Inspire Medical Systems, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$70.15+1.36 (+1.98%)
Close on Oct 19, 2026
- Market cap
- $2.03B
- P/E (TTM)
- 15.2
- Dividend yield
- –
Inspire Medical Systems, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $854.24M | $874.08M | $872.09M | $846.78M | $828.22M | $808.88M | $771.04M | $728.84M | $680.52M | $637.46M | $606.18M | $551.00M | 95.0% | +3.1% |
| International | $44.51M | $41.16M | $39.90M | $35.84M | $33.10M | $31.24M | $31.76M | $26.76M | $25.18M | $23.45M | $18.62M | $19.19M | 5.0% | +34.5% |
From the segment and revenue-disaggregation notes of Inspire Medical Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.